Related Experiment Video
Updated: Aug 25, 2026
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
IL-6 regulates CD44 cell surface expression on human myeloma cells
Abstract:
Multiple myeloma (MM) is a progressive B-lineage neoplasia characterized by the accumulation of slow proliferative malignant plasma cells in the bone marrow compartment where the microenvironment seems to be favorable for their growth and survival. Heparan sulfate proteoglycans such as syndecan-1 and CD44 are thought to play a central role in the survival signals provided by these bone marrow survival niches, which require complex interactions between myeloma cells, extracellular matrix, stromal cells and soluble factors. In this report, we demonstrate that interleukin-6 (IL-6), the main survival and growth factor for myeloma cells, strongly increases CD44 gene expression. In addition, we show that IL-6 modulates CD44 RNA alternative splicing and induces the overexpression of all CD44 variant exons. Finally, we show that IL-6-induced CD44 cell surface molecules have a functional polarized membrane distribution. As IL-6 secretion induced from bone marrow stromal cells by myeloma cells is partly mediated through direct cell-to-cell interaction involving CD44 adhesion molecules, our findings suggest that a CD44/IL-6 amplification loop plays a crucial role in myeloma cell survival.
Insights
Interleukin-6 (IL-6) boosts CD44 expression and splicing in multiple myeloma (MM) cells. This creates a CD44/IL-6 loop, enhancing survival signals in the bone marrow microenvironment for these cancer cells.
Area of Science:
- Hematology
- Cancer Biology
- Molecular Biology
Background:
- Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow.
- Bone marrow microenvironment supports MM cell survival through complex cell interactions.
- Heparan sulfate proteoglycans, including CD44, are implicated in MM cell survival signals.
Purpose of the Study:
- To investigate the role of Interleukin-6 (IL-6) in regulating CD44 expression and function in MM.
- To elucidate the molecular mechanisms linking IL-6 signaling to CD44 in the context of MM survival.
Main Methods:
- Gene expression analysis to assess CD44 levels upon IL-6 stimulation.
- RNA alternative splicing assays to identify IL-6-mediated changes in CD44 variants.
- Cell surface expression and localization studies of CD44 in response to IL-6.
Main Results:
- IL-6 significantly upregulates CD44 gene expression in MM cells.
- IL-6 influences CD44 RNA alternative splicing, leading to overexpression of variant exons.
- IL-6-induced CD44 molecules exhibit polarized distribution on the cell membrane.
- CD44-mediated cell-to-cell interactions contribute to IL-6 secretion by bone marrow stromal cells.
Conclusions:
- A positive feedback loop between CD44 and IL-6 is identified, crucial for MM cell survival.
- This CD44/IL-6 amplification loop represents a potential therapeutic target in multiple myeloma.
- Understanding these interactions provides insights into the MM bone marrow niche's role in disease progression.
